News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Adjunctive HBOT beneficial for DFUs
23 Jun 2026
byAudrey Abella
A meta-analysis presented at ADA 2026 supports the benefits of hyperbaric oxygen therapy (HBOT) for ulcer healing and reducing the risk of major amputation in individuals with diabetic foot ulcers (DFUs).
Adjunctive HBOT beneficial for DFUs
23 Jun 2026
ARACOG: Is there a difference in cognitive effects between darolutamide and enzalutamide?
23 Jun 2026
byNatalia Reoutova
ARACOG, a phase II randomized trial, reports a significantly greater decline in objectively assessed cognitive function for advanced prostate cancer patients treated with enzalutamide vs darolutamide over 24 weeks, according to data presented at ASCO 2026.







